Diabetes treatment is constantly progressing, with new therapeutic options developing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of naturally occurring hormones involved in bloodglucose regulation. These novel agents demonstrate promising efficacy in controll

The management of diabetes has become with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and could improve the lives of individuals living with diabetes. Reta| acts